Semi-solid Dosage Forms: Creams, Ointments, and Gels

Semi-solid dosage forms are applied topically to skin or mucous membranes for local or systemic effects. They include ointments, creams, gels, pastes, and foams. Understanding their rheological properties, drug release mechanisms, and penetration enhancement strategies is essential for effective formulation.

Ointments are anhydrous or hydrous preparations with an oleaginous continuous phase. Hydrocarbon bases (white soft paraffin, liquid paraffin) are occlusive, immiscible with water, not easily washed off, and offer prolonged contact time — ideal for dry, scaly dermatoses. Absorption bases (Aquaphor, lanolin) contain emulsifying agents and can incorporate water up to 50% w/w, forming W/O emulsions. Emulsifying ointment bases (emulsifying wax + white soft paraffin) produce O/W products on addition of water. Water-miscible bases (polyethylene glycol ointments, PEG bases) are water-washable and suitable for moist or weeping lesions but less occlusive.

Creams are semi-solid emulsions — either O/W (aqueous cream) or W/O (oily cream). O/W creams are cosmetically elegant, non-greasy, easily washed off, and preferred for scalp and hairy areas. W/O creams are more occlusive and emollient. Cream stability is a particular challenge — phase separation, microbial contamination, and pH drift degrade product quality over shelf life. Emulsifying agents (cetrimide, cetostearyl alcohol with sodium lauryl sulphate forming BASF emulsifier) must be optimised. pH adjustment affects drug solubility and partitioning; for weak acids/bases, the Henderson-Hasselbalch equation predicts the pH at which drug achieves maximum concentration in the vehicle phase.

Gels are semirigid systems of a liquid phase held within a three-dimensional polymeric network. Hydrogels (carbomer/Carbopol, HPMC, sodium CMC, hyaluronic acid) have aqueous continuous phases — highly cosmetically acceptable, easily washable, and producing a cooling sensation on application. Carbomer gels require neutralisation (NaOH, triethanolamine) to develop viscosity; the carboxylate groups ionise and repel each other, expanding the polymer coil and gelling the system. Organogels use oleaginous continuous phases (beeswax in mineral oil).

Rheology describes the flow behaviour of semi-solids — critical for product performance, processability, and patient experience. Newtonian fluids (water, simple solutions) show constant viscosity regardless of shear rate. Pharmaceutical semi-solids exhibit non-Newtonian behaviour. Pseudoplastic (shear-thinning) materials decrease in viscosity with increasing shear rate, facilitating spreading. Plastic (Bingham) materials require a yield stress before flow begins, maintaining shape at rest (prevents sag in topicals). Thixotropic materials exhibit time-dependent viscosity recovery — beneficial for injectability of suspensions, disadvantageous for stable creams. Rheological characterisation uses viscometers (Brookfield) and oscillatory rheometry (storage modulus G', loss modulus G'').

Skin penetration is the central challenge for topical and transdermal formulations. The stratum corneum (SC), a 10–20 µm layer of corneocytes embedded in lipid lamellae, provides the primary barrier. Transcellular, intercellular (via lipid bilayers), and appendageal (hair follicles, sweat glands) routes exist; the intercellular lipid route dominates for most drugs. Drug flux (J) follows Fick's first law: J = DKC/h, where D = diffusion coefficient in SC, K = partition coefficient (SC/vehicle), C = drug concentration in vehicle, h = SC thickness.

Penetration enhancers increase drug flux by disrupting SC lipid organisation, extracting lipids, or increasing drug thermodynamic activity. Chemical enhancers: DMSO (too irritating clinically), oleic acid (disrupts lipid packing), Azone (1-dodecylazacycloheptan-2-one), propylene glycol, ethanol, and terpenes (menthol, limonene). Physical enhancers: iontophoresis (electrical field drives charged drug through appendageal route), sonophoresis (ultrasound creates transient pores in SC), microneedles (pierce SC to access dermis directly), and electroporation (high-voltage pulses create transient lipid disruption). Supersaturation strategies (volatile co-solvents evaporate on application, increasing drug thermodynamic activity above saturation) enhance flux without chemical disruption.

Drug release from semi-solid vehicles is assessed by in vitro permeation testing (IVPT) using Franz diffusion cells. Synthetic membranes or excised human/porcine skin are mounted between donor (formulation) and receptor (buffer) compartments; cumulative drug permeation is measured over time. FDA guidance requires IVPT for topical generic product approval (for locally acting products without systemic PK).